Reply to: 'Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?' and 'External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals'

Genesca Joan

首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Reply to: 'Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?' and 'External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals'

【24h】

Reply to: 'Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?' and 'External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals'

机译：回复：“肝细胞癌肝细胞癌监测乙型肝炎病毒灭绝：肝硬化测量比实验室纤维化标记更有用吗？” “HCV晚期慢性肝病患者口腔抗病毒患者患有HCV晚期慢性肝病的肝细胞癌非侵入性预测因子的外部验证”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Hepatology: The Journal of the European Association for the Study of the Liver》 |2020年第2期|共2页
作者
Genesca Joan;
展开▼
作者单位

Univ Autonoma Barcelona Vall dHebron Inst Recerca VHIR Hosp Univ Vall dHebron Liver Unit Dept;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Liver stiffness as a predictor of hepatocellular carcinoma behavior in patients with hepatitis C related liver cirrhosis [J] . Sameh A Lashen, Mohamed M Elshafei, Fahmy H Hablass, 国际肝胆胰疾病杂志（英文版） . 2020,第001期
2. Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers? [J] . Nabatchikova Ekaterina, Abdurakhmanov Dzhamal, Rozina Teona, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2020,第2期

机译：丙型肝炎病毒后肝细胞癌监测：肝硬化测量比实验室纤维化标记更有用吗？
3. External validation of non-invasive predictors of hepatocellular carcinoma in patients with HCV-related advanced chronic liver disease after oral antivirals [J] . Shiha Gamal Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2020,第2期

机译：口腔抗病毒后HCV相关晚期慢性肝病患者肝细胞癌非侵入性预测因子的外部验证
4. Changes in fibrotic markers in chronic hepatitis C patients treated with direct antiviral agents and the enhanced liver fibrosis score as a predictor of hepatocellular carcinoma [J] . Kawaguchi Toshihiro, Ide Tatsuya, Amano Keisuke, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：直接抗病毒治疗慢性丙型肝炎患者纤维化标志物的变化及增强肝纤维化评分作为肝细胞癌预测因子
5. Betatrophin Expression in Chronic Hepatitis C Patients: Does Contribute to Liver Injury-linked Metabolic Syndrome and Hepatocellular Carcinoma Development? [C] . Hendra Susanto, Nan-Shan Liou, Bogi Pratomo, International Conference on Life Sciences and Technology . 2020

机译：慢性丙型肝炎患者的BERATROPHIN表达：是否有助于肝损伤链接代谢综合征和肝细胞癌发育？
6. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients [O] . Xu Li, Hongqin Xu, Pujun Gao 2019

机译：基于4个因素的纤维化指数（FIB-4）预测慢性丙型肝炎病毒（HCV）患者的肝硬化和肝细胞癌
7. Reply to: “Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?” and “External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals” [O] . Joan Genescà 2020

机译：回复：“肝细胞癌肝癌病毒脱离后的肝细胞癌监测：肝硬化测量比实验室纤维化标记更有用吗？” “口腔抗病毒后HCV先进慢性肝病患者肝细胞癌非侵入性预测因子的外部验证”

著录项

相似文献

相关主题

期刊订阅